SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001140361-20-012717
Filing Date
2020-05-29
Accepted
2020-05-29 16:15:48
Documents
5

Document Format Files

Seq Description Document Type Size
1 SC 13D/A formsc13da.htm SC 13D/A 81043
2 EXHIBIT 99.5 ex99_5.htm EX-99.5 26155
3 EXHIBIT 99.6 ex99_6.htm EX-99.6 14727
4 EXHIBIT 99.7 ex99_7.htm EX-99.7 188349
5 EXHIBIT 99.8 ex99_8.htm EX-99.8 53952
  Complete submission text file 0001140361-20-012717.txt   366013
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Subject) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-41938 | Film No.: 20927971
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filed by) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences